Article
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state.
Nature communications - 5 Aug 2025
Martinez Fiesco Juliana A, Beilina Alexandra, Alvarez de la Cruz Astrid, Li Ning, Metcalfe Riley D, Cookson Mark R, Zhang Ping
Abstract excerpt
Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson's disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we present the cryo-electron microscopy structure of the LRRK2:14-3-32 autoinhibitory complex, revealing how a 14-3-3 dimer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
